Mark Bates

680 total citations
19 papers, 321 citations indexed

About

Mark Bates is a scholar working on Oncology, Cancer Research and Surgery. According to data from OpenAlex, Mark Bates has authored 19 papers receiving a total of 321 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 5 papers in Cancer Research and 4 papers in Surgery. Recurrent topics in Mark Bates's work include Cancer Cells and Metastasis (6 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Cancer Genomics and Diagnostics (3 papers). Mark Bates is often cited by papers focused on Cancer Cells and Metastasis (6 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Cancer Genomics and Diagnostics (3 papers). Mark Bates collaborates with scholars based in Ireland, United Kingdom and Australia. Mark Bates's co-authors include Sharon O’Toole, John O’Leary, Cara Martin, Robert D. Brooks, Stavros Selemidis, Doug A. Brooks, Bashir M. Mohamed, Mark P. Ward, Lucy Norris and Seán Hanniffy and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer.

In The Last Decade

Mark Bates

18 papers receiving 315 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark Bates Ireland	11	132	106	87	43	41	19	321
Michael M. Song United States	9	95 0.7×	197 1.9×	82 0.9×	30 0.7×	20 0.5×	15	388
Paula García‐Teijido Spain	5	284 2.2×	112 1.1×	91 1.0×	63 1.5×	20 0.5×	6	394
Pierre-Olivier Gaudreau Canada	7	201 1.5×	116 1.1×	45 0.5×	107 2.5×	18 0.4×	18	424
Meiling Wen China	8	90 0.7×	208 2.0×	173 2.0×	33 0.8×	11 0.3×	17	361
Valentina Marchesin France	6	84 0.6×	193 1.8×	126 1.4×	12 0.3×	16 0.4×	7	395
Siqi Li China	11	72 0.5×	251 2.4×	143 1.6×	39 0.9×	24 0.6×	28	426
Furong Chen China	8	72 0.5×	141 1.3×	90 1.0×	47 1.1×	7 0.2×	25	294
Irina Kerle Germany	3	166 1.3×	110 1.0×	110 1.3×	57 1.3×	30 0.7×	5	332
Chao Zeng China	10	111 0.8×	170 1.6×	84 1.0×	72 1.7×	6 0.1×	25	351
Anastasia L. Berg United States	8	76 0.6×	263 2.5×	128 1.5×	16 0.4×	13 0.3×	11	468

Countries citing papers authored by Mark Bates

Since Specialization

Citations

This map shows the geographic impact of Mark Bates's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Bates with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Bates more than expected).

Fields of papers citing papers by Mark Bates

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Bates. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Bates. The network helps show where Mark Bates may publish in the future.

Co-authorship network of co-authors of Mark Bates

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Bates. A scholar is included among the top collaborators of Mark Bates based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Bates. Mark Bates is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Bates, Mark, Laura Byrne, John Greene, et al.. (2025). FOXP3 is a favourable prognostic indicator in oesophageal adenocarcinoma. Pathology - Research and Practice. 275. 156216–156216.

Richards, William A., Yvan Beaussant, Rezvan Ameli, et al.. (2023). Psilocybin‐assisted group therapy in patients with cancer diagnosed with a major depressive disorder. Cancer. 130(7). 1137–1146. 33 indexed citations

Ward, Mark P., Karsten Hokamp, Yanmei Huang, et al.. (2023). Plasminogen activator inhibitor 1 is associated with high-grade serous ovarian cancer metastasis and is reduced in patients who have received neoadjuvant chemotherapy. Frontiers in Cell and Developmental Biology. 11. 1150991–1150991. 7 indexed citations

Bates, Mark, Bashir M. Mohamed, Mark P. Ward, et al.. (2023). Circulating tumour cells: The Good, the Bad and the Ugly. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1878(2). 188863–188863. 23 indexed citations

Mohamed, Bashir M., Mark P. Ward, Mark Bates, et al.. (2023). Ex vivo expansion of circulating tumour cells (CTCs). Scientific Reports. 13(1). 3704–3704. 10 indexed citations

Arya, Swati, et al.. (2021). Prognostic features of the tumour microenvironment in oesophageal adenocarcinoma. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1876(2). 188598–188598. 13 indexed citations

Ward, Mark P., Lucy Norris, Bashir M. Mohamed, et al.. (2021). Platelets, immune cells and the coagulation cascade; friend or foe of the circulating tumour cell?. Molecular Cancer. 20(1). 59–59. 97 indexed citations

Bates, Mark, et al.. (2020). YB-1: The key to personalised prostate cancer management?. Cancer Letters. 490. 66–75. 22 indexed citations

Ó’Riain, Ciarán, Sinéad Toomey, Kirsten M. Timms, et al.. (2020). Prevalence of tumor BRCA1 and BRCA2 dysfunction in unselected patients with ovarian cancer. Obstetrics & Gynecology Science. 63(5). 643–654. 6 indexed citations

10.

White, Christine, Mark Bates, Helen Keegan, et al.. (2020). Exposure to tobacco smoke measured by urinary nicotine metabolites increases risk of p16/Ki-67 co-expression and high-grade cervical neoplasia in HPV positive women: A two year prospective study. Cancer Epidemiology. 68. 101793–101793. 5 indexed citations

11.

Bates, Mark, Cathy Spillane, Michael Gallagher, et al.. (2020). The role of the MAD2-TLR4-MyD88 axis in paclitaxel resistance in ovarian cancer. PLoS ONE. 15(12). e0243715–e0243715. 11 indexed citations

12.

Bates, Mark, Julia Schneider, Gerrit Erdmann, et al.. (2019). Multiplex profiling identifies clinically relevant signalling proteins in an isogenic prostate cancer model of radioresistance. Scientific Reports. 9(1). 17325–17325. 6 indexed citations

13.

Duff, Eimear, Dean Huggard, Mark Bates, et al.. (2019). GP123 Altered systemic inflammatory response in paediatric mild traumatic brain injury. Abstracts. A80.2–A80. 1 indexed citations

14.

Bates, Mark, Fiona Furlong, Michael Gallagher, et al.. (2019). Too MAD or not MAD enough: The duplicitous role of the spindle assembly checkpoint protein MAD2 in cancer. Cancer Letters. 469. 11–21. 22 indexed citations

15.

Ffrench, Brendan, Claudia Gasch, Karsten Hokamp, et al.. (2017). CD10−/ALDH− cells are the sole cisplatin-resistant component of a novel ovarian cancer stem cell hierarchy. Cell Death and Disease. 8(10). e3128–e3128. 14 indexed citations

16.

White, Christine, Mark Bates, Helen Keegan, et al.. (2016). Triage of LSIL/ASC-US with p16/Ki-67 dual staining and human papillomavirus testing: a 2-year prospective study. Cytopathology. 27(4). 269–276. 24 indexed citations

17.

Sperinde, Jeff, Beatrice E. Bachmeier, Ahmed Chenna, et al.. (2016). Abstract P3-07-09: Quantitative p95HER2 protein expression is predictive of trastuzumab response in HER2-positive metastatic breast cancer. Cancer Research. 76(4_Supplement). P3–7. 1 indexed citations

18.

Gianni, Lorenzo, W. Eiermann, L. Pusztai, et al.. (2008). Biomarkers as potential predictors of pathologic complete response (pCR) in the NOAH trial of neoadjuvant trastuzumab in patients (pts) with HER2-positive locally advanced breast cancer (LABC). Journal of Clinical Oncology. 26(15_suppl). 504–504. 10 indexed citations

19.

Burns, David D., Stephanie S. Rude, Anne D. Simons, Mark Bates, & Michael E. Thase. (1994). Does learned resourcefulness predict the response to cognitive behavioral therapy for depression?. Cognitive Therapy and Research. 18(3). 277–291. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact